L p(a) was first described by Berg in 1963. 1 It differs from LDL by the presence of a glycosylated protein of variable mass, termed apolipoprotein(a), which is linked by a covalent bond to apoB 100 and has approximately 80% structural homology with plasminogen, a key protein of the coagulation cascade. 2 Most [3] [4] [5] [6] [7] but not all previous studies 8 -10 have shown that elevated Lp(a) is an independent risk factor for coronary heart disease. The exact mechanism by which Lp(a) confers cardiovascular risk is unknown; however, both proatherogenic and prothrombogenic effects have been hypothesized. 2, [11] [12] [13] The early stages of atherosclerosis are associated with changes in arterial function and structure that can now be studied noninvasively using high-resolution ultrasound. A key early event in atherosclerosis is endothelial dysfunction, 14, 15 which can be detected in systemic conduit arteries by measuring flow-mediated dilation. 16 Subtle structural changes, such as thickening of the arterial intima-media complex, also occur early in the atherosclerotic disease process. 17, 18 Many conventional risk factors, such as smoking, hypercholesterolemia, hypertension, and diabetes, have recently been shown to be significantly associated with impaired arterial endothelial function 19 and with increased arterial wall thickness, 20 -22 consistent with their accepted role in atherogenesis. Much less is known, however, about the effects of Lp(a) on these early markers of arterial disease in healthy asymptomatic subjects. The purpose of the present study was therefore to examine the effects of plasma Lp(a) levels on early functional and structural atherosclerotic vascular changes in a cohort of normal healthy subjects.
Methods

Subjects
We studied 241 healthy subjects aged 40Ϯ15 years, (range, 15 to 69 years; 116 men, 125 women). None of these subjects had any history or clinical signs of coronary atherosclerosis, diabetes mellitus, familial hypercholesterolemia, or homozygous homocystinuria. All subjects were white. The subjects were recruited from hospital staff and volunteers from the community. None of the subjects was taking any regular cardioactive medications. There were 190 nonsmokers (79%), 40 current smokers (17%) and 11 ex-smokers (4%). Lifetime smoking dose was categorized on basis of self-reported lifetime total pack-years smoked: nonsmokers (0 pack-years), very light (0 to 4 pack-years), light (5 to 9 pack-years), moderate (10 to 19 packyears), and heavy (Ն20 pack-years). There were 82 postmenopausal women and 59 of them (47% of all women) were taking hormonereplacement therapy: 41 were taking a combination of estrogen and progestin and 18 were on estrogen only (after hysterectomy). All studies were approved by the local committees on ethical practice, and all subjects gave informed consent.
Lipoprotein Measurements
Fasting serum levels of Lp(a) were determined using commercially available solid-phase 2-site immunoradiometric assay kits (Mercodia Apo(a) RIA, Mercodia AB), which measures the apolipoprotein(a) molecule. Fasting serum total cholesterol and triglyceride concentrations were measured using standard enzymatic methods (Boehringer Mannheim GmbH) with a fully automated analyzer (Hitachi 704 or 747; Hitachi Ltd). HDL cholesterol (HDL-C) was measured after precipitation with phosphotungstate-magnesium. The LDL-C concentration was calculated using the Friedewald formula. 23 
Ultrasound Studies
Ultrasound study to examine brachial artery flow-mediated dilation was performed in all subjects, and carotid artery ultrasound was performed for measurement of mean common carotid artery intimamedia thickness (IMT) in 71 participants (age, 42Ϯ13 years; range, 29 to 69 years), including 62 nonsmokers, 1 current smoker, and 8 ex-smokers. All studies were performed using an Acuson 128XP/10 mainframe (Acuson) with a 7.0-MHz linear array transducer.
Arterial Physiology Testing
The ultrasound method for measuring endothelium-dependent and smooth muscle-dependent arterial dilation has been described previously. 16, 24 In brief, brachial artery diameter was measured from B-mode ultrasound images. In all studies, scans were obtained at rest, during reactive hyperemia, again at rest, and after sublingual nitrate. The subjects lay quietly for Ն10 minutes before the first scan. The brachial artery was scanned in longitudinal section 2 to 15 cm above the elbow. Depth and gain settings were set to optimize images of the lumen-arterial wall interface, images were magnified using a resolution box function, and machine operating parameters were not changed during any study. When a satisfactory transducer position was found, the skin was marked and the arm remained in the same position throughout the study. A resting scan was recorded, and arterial flow velocity was measured using a Doppler signal. 16, 24 Increased flow was then induced by inflation of a pneumatic tourniquet placed around the forearm (distal to the scanned part of the artery) to a pressure of 250 mm Hg for 4.5 minutes, followed by release. A second scan was taken continuously for 30 seconds before and 90 seconds after cuff deflation, including a repeat flow velocity recording for the first 15 seconds after the cuff was released. Thereafter, 10 to 15 minutes was allowed for vessel recovery, after which a further resting scan was taken. Sublingual nitroglycerin in standard antianginal doses (glyceryl trinitrate spray 400 g or isosorbide dinitrate spray 2.5 mg) was then administered, and 3 to 4 minutes later the last scan was acquired.
Vessel diameter was measured in every case by independent observers who were blinded to the subject's clinical details and stage of the experiment. The arterial diameter was measured at a fixed distance from an anatomic marker (such as a fascial plane or a vein seen in cross-section) using ultrasonic calipers. Measurements were taken from the anterior to the posterior 'm' line at end diastole, incident with the R wave on a continuously recorded ECG. The 'm' line represents the edge of the intima-media interface in the ultrasound image of the arterial wall. For the reactive hyperemia scan, diameter measurements were taken 45 to 60 seconds after cuff deflation. Four cardiac cycles were analyzed for each scan, and the measurements for each observer were averaged. The vessel diameter in scans after reactive hyperemia and nitroglycerin administration was expressed as the percentage relative to the average diameter of the artery in the 2 resting (control) scans (100%). Volume flow at baseline and after cuff deflation were calculated from measurements of arterial flow velocity, heart rate, and vessel diameter, as previously described. 16 This method has been previously shown to be accurate and reproducible for measurement of small changes in arterial diameter, 25 with low interobserver error for measurement of flow-mediated and nitrate-induced arterial dilation. 16, 25 
Carotid Artery Studies
All scans were performed by operators following a predetermined, standardized scanning protocol for the right and left carotid arteries, as described by Salonen and Salonen 26 and Blankenhorn et al, 27 using images of the far wall of the distal 10 mm of the common carotid arteries. Three scanning angles were used in each case; anterior oblique, lateral, and posterior oblique. The image was focused on the posterior (far) wall, and images were recorded from the angle showing the greatest distance between the lumen-intima interface and the media-adventitia interface, as described previously. 26 All scans were recorded on super-VHS videotape for subsequent off-line analysis. Images were digitized using a video framegrabber interfaced with a personal computer and analyzed with custom-made analysis software. Two end-diastolic frames were selected, digitized, and analyzed for mean IMT, and the average reading from these 2 frames was calculated, for both right and left carotid arteries. We have previously reported good intraobserver and interobserver repeatability values, and within subject reproducibility, using this method. 28 The interobserver error for mean IMT was 0.035Ϯ0.03 mm (range, 0 to 1.17 mm; coefficient of variation [CV], 2.5%), and the intrasubject variability was 0.07Ϯ0.07 (range, 0 to 0.26 mm; CV, 6%).
Statistical Analysis
Descriptive data are expressed as meanϮSD, unless otherwise stated. Comparisons between groups were performed with independent samples t tests, nonparametric Mann-Whitney U tests, or 2 tests, as appropriate. Associations were examined by calculating univariate Spearman's correlation coefficients. Because IMT measurements correlated linearly with age in this data set, partial correlation coefficients were also calculated between the measured variables and age-adjusted IMT. Multivariate linear regression models were used to study the independent determinants of arterial function and structure. The values for vascular parameters were normally distributed. However, because the distributions for Lp(a) and triglycerides were skewed, their values were log 10 -transformed before regression analyses. Statistical significance was inferred at a P value Յ0.05. All statistical analyses were performed by using the Statistical Analysis System. 29 
Results
The study characteristics of the 241 healthy subjects are summarized in Table 1 
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Lp(a) and Arterial Function
The univariate associations between lipid variables, age, smoking status, and vascular reactivity data are shown in Table 2 . Lp(a) concentration showed no significant association with flow-mediated dilation (Figure 1 ) or nitratemediated dilation in the entire cohort, or in either sex (data not shown). Both flow-mediated and nitrate-mediated dilation were significantly and inversely related to LDL-C, LDL-C/ HDL-C ratio, and triglycerides and directly to HDL-C concentration. In a multivariate regression model, the independent determinants of flow-mediated dilation included LDL-C/HDL-C ratio (Pϭ0.017), smoking (Pϭ0.015), and vessel size (PϽ0.001) ( Table 3) . Independent determinants of nitrate-mediated dilation included LDL-C/HDL-C ratio (PϽ0.001), sex (PϽ0.001), and vessel size (PϽ0.001).
To examine the influence of extremely high Lp(a) levels on vascular reactivity, we compared subjects in the highest Lp(a) quintile (Lp(a)Ն30 mg/dL, nϭ47) with those in the lowest (Lp(a)Յ3 mg/dL, nϭ46). The level of 30 mg/dL represents the atherogenic threshold of plasma Lp(a) levels in most studies. 4 -7 Subjects with high Lp(a) levels had higher LDL-C concentrations (Pϭ0.012), but otherwise the 2 groups had similar characteristics and showed no differences in the values for either flow-mediated or nitrate-mediated dilation (PϾ0.7).
Lp(a) and Arterial Structure
The associations between IMT and the measured risk variables are also shown in Table 2 . Lp(a) concentrations showed no significant association with IMT in either group ( Figure  2) . IMT was significantly correlated with total cholesterol, LDL-C, LDL-C/HDL-C ratio, age, and triglycerides. Adjustment for age did not change the overall correlations or significances. For example, the partial correlation adjusted for age between Lp(a) and IMT remained nonsignificant (rϭ0.00, Pϭ0.99). Furthermore, when the correlation analyses were stratified by age (using the median value of 37 years as the cut-point), the overall correlations and significances for IMT remained essentially the same as those shown in Table  2 . In a multivariate regression model, IMT correlated significantly and directly with age (PϽ0.001) and LDL-C/HDL-C ratio (Pϭ0.03).
Discussion
Lp(a) levels in the highest population quintile (greater than Ϸ30 mg/dL) appear to be associated with approximately 2 to Regression coefficients indicate the change in FMD (%) predicted from one unit change in a single determinant when others are held constant. Smoking was entered as a categorical variable (nonsmoker, very light, light, moderate, heavy) on the basis of the history of pack-years smoked. The results were similar when Lp(a) was substituted by log-transformed Lp(a) values or when systolic or diastolic blood pressure was entered instead of mean blood pressure. The multiple r value for this model was 0.47.
3 times higher relative risk for cardiovascular events, compared with levels Ͻ30 mg/dL. This finding has been observed in men and women, and in several different regions of the world. 30 Nevertheless, the mechanism of risk conferred by Lp(a), and its interaction with other traditional atherogenic factors, remains obscure. In this relatively large study of arterial function and structure, we have shown that elevated Lp(a) has no significant association with endothelial dysfunction, impaired smooth muscle responses, or arterial wall thickening. By contrast, in the same population, other lipid risk factors such as elevated LDL-C or LDL-C/HDL-C ratio were significantly associated with preclinical evidence of arterial damage in accordance with previous studies. 19 -21,28 The best single correlate for early functional and structural atherosclerotic changes in this study was the LDL-C/HDL-C ratio, which has previously been found to be superior to measurement of serum LDL-C alone, as a predictor of coronary heart disease risk in epidemiologic studies. 31 Significant associations between risk factors and impaired nitrate-mediated vasodilation observed here suggest that early changes in the vessel wall during atherogenesis may not be limited to the endothelium, and that the reduction in vasodilation to exogenous sources of nitric oxide may be partly mediated by changes in vascular smooth muscle responsiveness. 32 Previous results regarding the relationship between Lp(a) and early functional and structural changes of atherosclerosis have been inconsistent. In smaller studies, elevated Lp(a) concentration has been shown to be related to peripheral endothelial dysfunction in children with familial hypercholesterolemia who have markedly elevated LDL-C levels, but not in normocholesterolemic control children, 33 healthy adolescents, 34 or normal young adults. 35 In patients with angiographically normal or minimally diseased coronary arteries, elevated plasma Lp(a) levels have been linked to impaired coronary vasomotion induced by acetylcholine infusion 36, 37 ; however, coronary vasodilatory response to dipyridamole has not been significantly related to plasma Lp(a) levels in healthy young subjects. 38 The results concerning the relationship between high Lp(a) levels and early arterial structural changes are also inconsistent. Elevated serum Lp(a) concentrations have been associated with subclinical carotid atherosclerosis in patients with non-insulin-dependent diabetes mellitus in some studies, 39 but not all. 40 Furthermore, high Lp(a) has been shown to be a risk factor for increased IMT in patients with severe hypercholesterolemia, but not in normocholesterolemic subjects. 41 Lavrencic et al 42 found no association between IMT and Lp(a) concentration in a pooled cohort of young patients with familial hypercholesterolemia and controls. By contrast, the large data set from the Atherosclerosis Risk in Communities study has shown that Lp(a) concentration is weakly but significantly correlated with increased IMT values, both in white and African American men and women. 43 
Mechanisms
Owing to its structural homology with LDL and plasminogen, Lp(a) has both atherogenic and thrombogenic potential. 44 It is not yet known, however, whether Lp(a) has a role in the early phases (initiation, development) or late phases (thrombosis) of occlusive arterial disease, or whether the associated cardiovascular risk is mediated by some other mechanism. Several mechanisms have been proposed to explain the association between Lp(a) and atherosclerosis. In vitro, Lp(a) migrates to the vessel wall 45 binds to macrophages, 12 may be internalized in these cells after oxidative modification, 12, 46 and subsequently may be found in atherosclerotic plaques. 11 Lp(a) has also been shown to promote the proliferation of smooth muscle cells 47 and to enhance the expression of intracellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. 48 There are fewer in vivo studies of the potentially proatherogenic effects of Lp(a), however, and our current data support the suggestion that elevated Lp(a) levels might confer risk by potential effects on thrombogenesis, 13, 49 rather than by promoting early atherogenic events.
Methodology
Recently, developments in ultrasound have provided methods for the noninvasive study of the functional and structural changes that occur in arteries in early atherosclerosis in vivo, and therefore offer an opportunity to assess the relative importance of different vascular risk factors in the preclinical stages of atherosclerosis. In this study, we have used a recently described and validated test of arterial endothelial function that reflects mainly the endothelium-dependent release of nitric oxide in response to a physical stimulus (shear stress). 50, 51 Previous in vitro and in vivo data have implicated arterial endothelial dysfunction as a key early event in atherosclerosis, 14, 15 preceding plaque formation and clinical events. Our current observations about Lp(a) therefore suggest that this factor does not influence endothelial function in otherwise healthy subjects. Endothelial function tested by the currently described method in the brachial artery correlates well with coronary endothelial function 52 and with the angiographically determined extent of coronary atherosclerosis. 53 Endothelium-independent, smooth-muscle-dependent dilation was studied by measuring the arterial dilator response to sublingual nitrates, which produce vasorelaxation by the cGMP pathway. Early structural changes were studied by measuring the IMT of the common carotid artery. This measurement also correlates significantly with traditional vascular risk factors 20 -22 and the severity and extent of coronary, carotid, and femoral atherosclerotic plaques, 28, 54 and also predicts the likelihood of future cardiovascular events in at-risk population groups. 22, 26 Both these surrogate measures of early atherosclerosis may be measured accurately and reproducibly in human subjects. 25, 28, 55 
Limitations
The present study examined the relationships between Lp(a) and arterial reactivity and early atherosclerosis crosssectionally. A more ideal approach would be prospective study of subjects before and after therapeutic interventions aimed at altering serum Lp(a) levels. Because Lp(a) levels are mainly determined genetically 56 and there is no effective means to reduce Lp(a) levels without simultaneously affecting the levels of other lipoproteins, [57] [58] [59] [60] such an interventional study would be difficult to perform. We have studied only those volunteers approached and willing to consent to studies on the effects of risk factors on arterial physiology, and therefore some selection bias may be present. Nevertheless, the asymptomatic subjects studied noninvasively presented with a wide range of ages, cholesterol and blood pressure levels, and smoking histories, which include the average population values. The number of subjects with data on arterial structure was limited, and this subgroup included very few smokers. Nevertheless, significant associations were present in this group between IMT and lipid risk factors other than Lp(a).
Conclusions
In summary, we did not find any influence of Lp(a) levels on either the functional or structural vascular changes associated with early stages of atherosclerosis in asymptomatic subjects. These data suggest that elevated Lp(a) levels do not confer cardiovascular risk by promoting early atherogenesis in vivo.
